HPV treatment study for women with HIV in Kenya
Part of Cancer, Immune system & allergy, Infections, Women’s health & pregnancy clinical trials.
This trial tests whether giving a medicine called 5-fluorouracil (5FU) after a procedure called thermal ablation helps clear HPV better than ablation alone. The study is for women with HIV in Kenya who have an HPV infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 25 or older.
- You are HIV-positive and have been taking HIV medication for at least 60 days.
- Your HPV test came back positive.
- You are not currently pregnant or breastfeeding.
- You agree to use birth control during the study if you could become pregnant.
- You have not had a hysterectomy (surgery to remove the uterus) or a history of cervical, vulvar, or anal cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to help women with HIV get screened for cervical cancer: a clinic-based approach versus a combined clinic and community outreach program. You may be able to provide samples yourself at a clinic or at home to test for HPV, the virus that can cause cervical cancer.
This study compares two treatments (Thermal Ablation and LEEP) to lower the risk of cervical cancer in women living with HIV. It aims to find which option works better and is safer for this group.
This Phase 1 study tests FluBHPVE6E7, a new treatment designed to help the immune system respond to HPV16. It mainly checks safety and the best dose, and may help your body clear or control HPV over time.
This study looks at whether getting the HPV vaccine along with regular cervical cancer screening (using an HPV test) can help prevent cervical cancer in women living with HIV. It is designed to be done as part of your usual HIV clinic visits, making it easier for you to take part.
This trial compares two ways to help women living with HIV get screened for cervical cancer: one uses only clinic visits, the other adds community outreach and self-testing for HPV at home. It aims to increase screening rates and catch early signs of cervical cancer.
This study looks at giving HPV vaccines to mothers and daughters in Kenya. It tests whether community meetings help more families get the vaccine, which can prevent cervical cancer.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.